Leica Biosystems, Germany, has just reported that an affiliate has entered into a definitive agreement to acquire Aperio, Vista, Calif, a provider of ePathology solutions.
Aperio will be integrated into Leica Biosystems, which specializes in anatomical pathology solutions.
Together, the two businesses will leverage each other’s strengths to grow and expand digital pathology into the global life science and health care markets, says Leica.
The integrated business will provide solutions in each step of the anatomical pathology workflow, from sample preparation and staining, to imaging and reporting. The company will continue to offer both the Aperio and the existing Leica portfolio of digital pathology solutions, so that customers can choose a solution that meets their individual needs.
Aperio ePathology Solutions include whole slide scanners, a NETWORK solution that enables remote, real-time viewing and easy distribution of images for peer review, collaboration, and consultation. Its PRECISION solution provides pathologists with easy-to-use quantitative image analysis to improve research and clinical productivity, reproducibility, and consistency. Customers include clinicians and researchers working in hospitals, reference labs, pharma, and research institutions.
CLP‘s August issue, just out in print, due to be posted on the home page soon, features a cover story titled "ePATHOLOGY: An Evolutionary Change," authored by Jared N. Schwartz, MD, PhD, Aperio’s chief medical officer, and consulting professor of pathology, Stanford University Medical Center, Palo Alto, Calif.
[Source: Leica Biosystems]
